510(k) K182001
K182001 is an FDA 510(k) premarket notification submitted by SEKISUI Diagnostics, LLC for the device "Acucy Influenza A&B Test with the Acucy System". The FDA issued a decision of Substantially Equivalent on Dec 17, 2018. The device falls under product code PSZ (Devices Detecting Influenza A, B, And C Virus Antigens), a Class II device regulated under 21 CFR 866.3328. SEKISUI Diagnostics, LLC has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 17, 2018
- Date Received
- Jul 26, 2018
- Clearance Type
- Dual Track
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Devices Detecting Influenza A, B, And C Virus Antigens
- Device Class
- Class II
- Regulation Number
- 866.3328
- Review Panel
- MI
- Submission Type
- 510(k)
An influenza virus antigen detection test system is a device intended for the qualitative detection of influenza viral antigens directly from clinical specimens in patients with signs and symptoms of respiratory infection.
Need the full FDA record for SEKISUI Diagnostics, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.